
ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.
Ultralife Corporation designs, manufactures, installs and maintains electrical, communication and electronic systems worldwide. The company is headquartered in Newark, New York.
| Revenue (TTM) | $187.24M |
| Gross Profit (TTM) | $45.65M |
| EBITDA | $12.73M |
| Operating Margin | 9.01% |
| Return on Equity | -4.91% |
| Return on Assets | 2.10% |
| Revenue/Share (TTM) | $11.24 |
| Book Value | $7.78 |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 0.65 |
| EV/Revenue | 0.868 |
| EV/EBITDA | 149.65 |
| Quarterly Earnings Growth (YoY) | 200.00% |
| Quarterly Revenue Growth (YoY) | -1.30% |
| Shares Outstanding | $16.66M |
| Float | $9.62M |
| % Insiders | 3.22% |
| % Institutions | 73.89% |
Volatility is currently expanding

ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.

Ultralife NASDAQ: ULBI reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications businesses.

NEWARK, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: Sales of $47.9 million compared to $48.6 million for the 2025 second quarter Gross profit of $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, for the 2025 second quarter; excluding a $1.1 million net IEEPA refund received in the 2026 second quarter, gross margin was 26.6% Operating income of $3.4 million, including one-time costs of $0.9 million, compared to $2.3 million including one-time costs of $0.3 million for the 2025 second quarter GAAP EPS of $0.15 compared to $0.05 for the 2025 second quarter Adjusted EBITDA of $6.1 million compared to $4.1 million for the 2025 second quarter Backlog of $117.5 million compared to $115.1 million exiting the first quarter of 2026 “For the second quarter we delivered a 760-basis point improvement in gross profit margin compared to the first quarter, including the contribution of the net IEEPA refund.

NEWARK, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2026, before the market opens on Friday, August 7, 2026.

Discover why Zacks rates Ultralife as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore ULBI's struggles with execution risks, margin pressure and commercialization delays that could delay its earnings recovery.

Ultralife NASDAQ: ULBI reported a first-quarter loss for fiscal 2026 as lower sales, production disruptions and higher one-time costs weighed on results, even as management pointed to a record backlog and new product activity as signs of future growth.

Ultralife Corporation (ULBI) Q1 2026 Earnings Call Transcript

NEWARK, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2026 as follows:
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ULBI and any ticker you trade — then tracks every position and per-strategy win rate.